Mechanistically, through comprehensive biochemical screening and tumor samples profiling, we identified UCHL3 as a crucial deubiquitinase that binds explicitly to JAK2-phosphorylated BRD4 to maintain its stabilization. The gene discussed is UCHL3; the disease is neoplasm.